Acute lymphoblastic leukaemia trials in Singapore

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  Singapore

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00
• Phase 3Taking people
  A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

  Where

  Singapore

  Age

  18 years and over

  People

  350 worldwide

  Run by

  Ascentage Pharma Group Inc.

  See details and how to joinNCT06051409 · EU 2024-511496-14-00
• Phase 1/2Taking people
  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Where

  Singapore

  Age

  12 years and over

  People

  606 worldwide

  Run by

  Sumitomo Pharma America, Inc.

  See details and how to joinNCT04988555
• Phase 2Taking people
  Ma-Spore ALL 2020 Study

  Where

  Singapore

  Age

  Up to 40 years

  People

  500 worldwide

  Run by

  National University Hospital, Singapore

  See details and how to joinNCT06336395
• Phase 2Taking people
  CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

  Where

  Singapore

  Age

  0 years to 70 years

  People

  40

  Run by

  KK Women's and Children's Hospital

  See details and how to joinNCT05648019